Substance abuse prevention

Last updated
Rational scale to assess the harm of drugs Rational scale to assess the harm of drugs (mean physical harm and mean dependence).svg
Rational scale to assess the harm of drugs

Substance abuse prevention, also known as drug abuse prevention, is a process that attempts to prevent the onset of substance use or limit the development of problems associated with using psychoactive substances. Prevention efforts may focus on the individual or their surroundings. A concept that is known as "environmental prevention" focuses on changing community conditions or policies so that the availability of substances is reduced as well as the demand. [1] Individual Substance Abuse Prevention, also known as drug abuse prevention involves numerous different sessions depending on the individual to help cease or reduce the use of substances. The time period to help a specific individual can vary based upon many aspects of an individual. The type of Prevention efforts should be based upon the individual's necessities which can also vary. Substance use prevention efforts typically focus on minors and young adults – especially between 12–35 years of age. Substances typically targeted by preventive efforts include alcohol (including binge drinking, drunkenness and driving under the influence), tobacco (including cigarettes and various forms of smokeless tobacco), marijuana, inhalants (volatile solvents including among other things glue, gasoline, aerosols, ether, fumes from correction fluid and marking pens), coke, methamphetamine, steroids, club drugs (such as MDMA), and opioids. Community advocacy against substance use is imperative due to the significant increase in opioid overdoses in the United States alone. It has been estimated that about one hundred and thirty individuals continue to lose their lives daily due to opioid overdoses alone. [2]

Contents

Protective and risk factors

Environmental and internal are two main factors that contribute to the likelihood of developing a substance use disorder. Environmental factors in the individual's adolescence include: child abuse, exposure to substances, lack of supervision, media influence, and peer pressure. Drug activity in an individual's community may normalize the usage of drugs. [3] [ page needed ] The result of substance use can be caused due to stressful situations within household which can result of learned behavior of the is of substances to cope. Similarly. [4] if an individual is placed through treatment and then placed back into the same environment that they left, there is a great chance that person will relapse to their previous behavior. Internal factors that are within the child or personality-based are self-esteem, poor social skills, stress, attitudes about drugs, mental disorder and many others. [5] A few more factors that contribute to teen drug abuse are lack of or poor parent to child communication, [6] unsupervised accessibility of alcohol at home, having too much freedom and being left alone for long periods of time. [7] Additionally, there is evidence that gender moderates the effect of family, school and peer factors on adolescent substance use. [8] For example, some studies report that not living with both biological parents or having poor parent-adolescent communication is associated with substance use, especially in female adolescents. [9] [10]

Main risk periods for substance use occur during major transitions in a child's life. Some of these transitional periods that could increase the possibility of youth using drugs are puberty, moving, divorce, leaving the security of the home, and entering school. School transitions such as those from elementary to middle school or middle school to high school can be times that children and teenagers make new friends and are more susceptible to fall into environments where there are drugs available. One recent study examined that by the time are seniors in high school, "almost 70 percent will have tried alcohol, half will have taken an illegal drug, nearly 40 percent will have smoked a cigarette, and more than 20 percent will have used a prescription drug for a nonmedical purpose” (Johnston et al., 2013). [11] Binge drinking has also, been shown to increase once an individual leaves the home to attend college or live on their own. [12]

Most youths do not progress towards regular, heavy substance use after experimentation. Research has shown, when drug use begins at an early age, there is a greater possibility for addiction to occur. [13] Three exacerbating factors that can influence substance use to become substance use are social approval, lack of perceived risks, and availability of drugs in the community. Youths from certain demographics are also at higher risk for addiction. These groups include those suffering from a mental illness and who comes from a family history of addiction. Yet, some[ quantify ] teens living with dual diagnosis prove that there is not always a causal relationship between mental illness and a substance use disorder. Moreover, when addiction occurs, youth are more likely to require teen rehab as a form of treatment. [14] [ promotion? ] Most young adults have a false perception that they may be invincible. These individuals believe changes won't be made until an extreme event happens i.e. a friend overdoses, a car accident or even death. Even then it is not likely that they will see the correlation between use and trauma.

Substance use includes risk factors that correlate to one's health that can include HIV/AIDS, Hepatitis B virus, and Hepatitis C virus. These viral infections can be easily be spread by injections from needles. [15]

Plans on preventing substance use

Family based prevention programs

"Prevention programs can strengthen protective factors among young children by teaching parents better family communication skills, appropriate discipline styles, firm, and consistent rule enforcement, and other family management approaches. Research confirms the benefits of parents providing consistent rules and discipline, talking to children about drugs, monitoring their activities, getting to know their friends, understanding their problems and concerns, and being involved in their learning. The importance of the parent-child relationship continues through adolescence and beyond" (National Institute of Drug Abuse, 2003). [16] Research has been done showing that the measures taken within family prevention has been shown to reduce the risk of substance abuse. [17]

Smit, Verdurmen, Monshouwer, and Smil conducted research analysis to measure the effectiveness of family interventions about teen and adolescence drug and alcohol use. [18] According to their data, use of alcohol and other drugs is very common in Western societies. For example, 18% of the young adults between the ages of 12–14 years old in the US have indulged in binge drinking. According to quantities in 2006, 73% of 16-year-old US students were reported having used alcohol; In Northern Europe, this is 90%. Since early use of alcohol and other substances may cause serious health, immediate solutions to these problem are required . [19]

School-based prevention programs

US Navy Master-at-Arms 1st Class Michael Turner of Mobile Security Squadron Two (MSS-2) collects information at the Substance Abuse Prevention Summit US Navy 061117-N-8132M-023 Master-at-Arms 1st Class Michael Turner of Mobile Security Squadron Two (MSS-2) collects information at the Substance Abuse Prevention Summit held at the Snug Harbor Officer's Club on board Naval Amph.jpg
US Navy Master-at-Arms 1st Class Michael Turner of Mobile Security Squadron Two (MSS-2) collects information at the Substance Abuse Prevention Summit
Drama based education to motivate participation in substance use prevention. (media from BioMed Central)

There are a number of community-based prevention programs and classes that aim to educate children and families about the harms of substance use. Schools began introducing substance use oriented classes for their students in grades as low as preschool. The inclusion of prevention studies into classroom curricula at a young age has been shown to help to break early behaviors that could be signs of an increased risk for developing a substance use disorder in the future. Around 40% of children have tried alcohol by the time that they are ten.[ citation needed ]

Many organizations educate, advocate, and collaborate to prevent substance use. Some programs may begin by allowing students to be interactive and learn skills such as how to refuse drugs. This is proven to be a more effective method than strictly educational or non-interactive ones. When direct influences (e.g., peers) and indirect influences (e.g., media influence) are addressed, the program is better able to cover broad social influences that most programs do not consider. Programs that encourage a social commitment to abstain from drugs show lower rates of drug use. Getting the community outside of the school to participate and also using peer leaders to facilitate the interactions tend to be an effective facet of these programs. Even though adolescents are frequently aware of the negative consequences of substance use, they may start and maintain this habit. Adolescents, their parents, and other family members are the focus of comprehensive preventive and control programs in schools and the community. These effective actions help promote children's development of a positive sense of self-worth and sufficiency, to stop adolescent risk behavior, and to help them build strong, healthy coping skills. [20] Lastly, teaching youth and adolescents skills that increase resistance skills in social situations may increase protective factors in that population. [21] [22]

Community prevention programs

Prevention programs work at the community level with civic, religious, law enforcement, and other government organizations to enhance anti-drug norms and pro-social behaviors. Many programs help with prevention efforts across settings to help send messages through school, work, religious institutions, and the media. Research has shown that programs that reach youth through multiple settings can remarkably influence community norms. Community-based programs also typically include the development of policies or enforcement of regulations, mass media efforts, and community-wide awareness programs. [23] Increasing health education in the community also plays a role in helping to decrease the consequences of substance use.

On a community level, established safe injection sites that provide a hygienic space supervised by licensed healthcare professionals allow for safe monitoring of participants and provide health education and care to prevent overdose. Another way to help prevent overdose, especially regarding opioids, is the increased access and knowledge of naloxone. Naloxone is the standard opioid overdose reversal agent. [24] Studies show Overdose Education and Naloxone Distribution (OEND) programs decrease the rate of rate of deaths from opioid overdose. [25] Naloxone comes in different routes of administration such as, an injection that's administered intravenously, intramuscular, or subcutaneously and a nasal spray. Naloxone injection and the nasal spray are both commonly used in adults and children who are going through drug overdose because it is successful in reversing the overdose effects [26] [27] As a safety precaution, patients taking opioids are recommended to always carry naloxone with them and should replace the naloxone regularly, via reference to the expiration date. [28] Research has shown that extra effort in providing incentives, flexible schedules, personal contact, and the public support of important community leaders helps attract and retain program participants.

Medical-based prevention programs

Prevention within the medical field plays a large role in impeding substance abuse. This is largely seen when looking at the role nurses play in the opioid crisis in the United States. One program that nurses can get involved with regarding the opioid epidemic is medication-assisted treatment (MAT) system. This system is an evidence based approach that uses both therapy and medication to treat patients struggling with opioid addiction. [29] Special training is required for nurses who want to participate in this program, meaning there are a limited number of nurses who can partake, however, it has greatly reversed the number of overdoses and deaths from opioids in the United States. Another type of program that nurses can assist in to reduce opioid addiction is called "eat, sleep, console." This is an approach that nurses can take when treating patients that can reduce which medications a patient needs and how long their hospital stay is. This is used for newborns that became exposed to opioids in utero, and it gives nurses the opportunity to educate their patients on how to reduce the side effects of addiction. [30] Looking at it in whole, there are several different programs within the medical field that are used to treat substance abuse.

Levels of Prevention

There are three types of prevention which are all aimed to help reduce and or help deal with health problems that can be caused by substance use. The first intervention when dealing with substance use is primary use which involves ceasing the result of substances being used before it happens. Examples of primordial prevention include preventing the development of risk factors (e.g., depression) that increase a person's chances of developing a future substance use disorder. Examples of primary substance prevention would be the promotion of no interaction with the drug. Tertiary prevention is when the individual has to receive treatment for the substance that has been consumed. Examples include rehab & intensive outpatient therapy are examples of a few short-term preventions. Tertiary prevention involves an individual such as one suffering from substance use to receive treatment such as rehab or an intensive therapy but the process of recuperating will be longer due to the intense amount of intake within the body. [31]

National recognition of substance use prevention

In 2011 President Obama issued October as National Substance Abuse Prevention Month. It pays tribute to all people working hard to prevent use in communities and working hard to make a safer drug-free country. [32]

Millions of Americans currently participate in Red Ribbon Week activities, according to the National Family Partnership (NFP)—the Red Ribbon campaign's national organizer. The Drug Enforcement Administration, a Federal partner in Red Ribbon Week, describes it as “the most far-reaching and well-known drug prevention event in America.” Through the efforts of the NFP, other national organizations, Federal and State agencies, and communities, Red Ribbon Week has become more than a call to action. It has grown to be a unifying symbol of family and community dedication to preventing the use of alcohol, tobacco, and illicit drugs among youth. [33]

In 2017, the FDA created the Opioid Policy Steering Committee (OPSC) to help guide FDA efforts in fighting this opioid epidemic specifically focusing on topics of new addiction, treatment support and development, assessment of risk over benefit and overall enforcement. [34]

In the United States, there is a Substance Abuse and Mental Health Services Administration that provides a free 365 days per year 24-hour phone service. Their purpose is to provide information or therapy referrals to anyone experiencing substance use disorders or mental health issues. This national helpline number is (1800-662-HELP (4357)). [35]

The NIH has made research-based guides available to help prevent substance use and addiction in youth. [36] One guide speaks on prevention for early childhood. [37] Another talks about prevention in children and adolescents. [38]

Successful intervention programs typically involve high levels of interactivity, time-intensity, and universal approaches that are delivered in the middle school years. These program characteristics aligned with many of the effective program elements found in previous reviews exploring the impact of school-based drug prevention on licit drug use.

More recently, a $3.3 billion federal spending bill has been passed by Congress, which will be used to support prevention, treatment, and law enforcement activities, supporting state and local governments. [39]

See also

Related Research Articles

<span class="mw-page-title-main">Methadone</span> Opioid medication

Methadone, sold under the brand names Dolophine and Methadose among others, is a synthetic opioid agonist used for chronic pain and also for opioid use disorder. It is used to treat chronic pain, and it is also used to treat addiction to heroin or other opioids. Prescribed for daily use, the medicine relieves cravings and removes withdrawal symptoms. Withdrawal management using methadone can be accomplished in less than a month, or it may be done gradually over a longer period of time, or simply maintained for the rest of the patient's life. While a single dose has a rapid effect, maximum effect can take up to five days of use. After long-term use, in people with normal liver function, effects last 8 to 36 hours. Methadone is usually taken by mouth and rarely by injection into a muscle or vein.

<span class="mw-page-title-main">Substance abuse</span> Harmful use of drugs

Substance abuse, also known as drug abuse, is the use of a drug in amounts or by methods that are harmful to the individual or others. It is a form of substance-related disorder. Differing definitions of drug abuse are used in public health, medical, and criminal justice contexts. In some cases, criminal or anti-social behavior occurs when the person is under the influence of a drug, and long-term personality changes in individuals may also occur. In addition to possible physical, social, and psychological harm, the use of some drugs may also lead to criminal penalties, although these vary widely depending on the local jurisdiction.

<span class="mw-page-title-main">Harm reduction</span> Public health policies which lessen negative aspects of problematic activities

Harm reduction, or harm minimization, refers to a range of intentional practices and public health policies designed to lessen the negative social and/or physical consequences associated with various human behaviors, both legal and illegal. Harm reduction is used to decrease negative consequences of recreational drug use and sexual activity without requiring abstinence, recognizing that those unable or unwilling to stop can still make positive change to protect themselves and others.

<span class="mw-page-title-main">Naloxone</span> Opioid receptor antagonist

Naloxone is an opioid antagonist: a medication used to reverse or reduce the effects of opioids. For example, it is used to restore breathing after an opioid overdose. Effects begin within two minutes when given intravenously, five minutes when injected into a muscle, and ten minutes as a nasal spray. Naloxone blocks the effects of opioids for 30 to 90 minutes.

<span class="mw-page-title-main">Alcohol abuse</span> Misuse of alcoholic beverages resulting in negative consequences

Alcohol abuse encompasses a spectrum of unhealthy drinking behaviors which range from consuming more than 2 drinks per day on average for men, or more than 1 drink per day on average for women, to binge drinking or alcohol use disorder.

Drug rehabilitation is the process of medical or psychotherapeutic treatment for dependency on psychoactive substances such as alcohol, prescription drugs, and street drugs such as cannabis, cocaine, heroin or amphetamines. The general intent is to enable the patient to confront substance dependence, if present, and stop substance misuse to avoid the psychological, legal, financial, social, and physical consequences that can be caused.

<span class="mw-page-title-main">Opioid use disorder</span> Medical condition

Opioid use disorder (OUD) is a substance use disorder characterized by cravings for opioids, continued use despite physical and/or psychological deterioration, increased tolerance with use, and withdrawal symptoms after discontinuing opioids. Opioid withdrawal symptoms include nausea, muscle aches, diarrhea, trouble sleeping, agitation, and a low mood. Addiction and dependence are important components of opioid use disorder.

Substance dependence, also known as drug dependence, is a biopsychological situation whereby an individual's functionality is dependent on the necessitated re-consumption of a psychoactive substance because of an adaptive state that has developed within the individual from psychoactive substance consumption that results in the experience of withdrawal and that necessitates the re-consumption of the drug. A drug addiction, a distinct concept from substance dependence, is defined as compulsive, out-of-control drug use, despite negative consequences. An addictive drug is a drug which is both rewarding and reinforcing. ΔFosB, a gene transcription factor, is now known to be a critical component and common factor in the development of virtually all forms of behavioral and drug addictions, but not dependence.

<span class="mw-page-title-main">Opioid overdose</span> Medical condition

An opioid overdose is toxicity due to excessive consumption of opioids, such as morphine, codeine, heroin, fentanyl, tramadol, and methadone. This preventable pathology can be fatal if it leads to respiratory depression, a lethal condition that can cause hypoxia from slow and shallow breathing. Other symptoms include small pupils, and unconsciousness; however, its onset can depend on the method of ingestion, the dosage and individual risk factors. Although there were over 110,000 deaths in 2017 due to opioids, individuals who survived also faced adverse complications, including permanent brain damage.

<span class="mw-page-title-main">Substance use disorder</span> Continual use of drugs (including alcohol) despite detrimental consequences

Substance use disorder (SUD) is the persistent use of drugs despite substantial harm and adverse consequences as a result of their use. The National Institute of Mental Health (NIMH) states that "Substance use disorder (SUD) is a treatable mental disorder that affects a person's brain and behavior, leading to their inability to control their use of substances like legal or illegal drugs, alcohol, or medications. Symptoms can be moderate to severe, with addiction being the most severe form of SUD". Substance use disorders (SUD) are considered to be a serious mental illness that fluctuates with the age that symptoms first start appearing in an individual, the time during which it exists and the type of substance that is used. It is not uncommon for those who have SUD to also have other mental health disorders. Substance use disorders are characterized by an array of mental/emotional, physical, and behavioral problems such as chronic guilt; an inability to reduce or stop consuming the substance(s) despite repeated attempts; operating vehicles while intoxicated; and physiological withdrawal symptoms. Drug classes that are commonly involved in SUD include: alcohol (alcoholism); cannabis; opioids; stimulants such as nicotine, cocaine and amphetamines; benzodiazepines; barbiturates; and other or unknown substances.

<span class="mw-page-title-main">Addiction</span> Disorder resulting in compulsive behaviours

Addiction is a neuropsychological disorder characterized by a persistent and intense urge to use a drug or engage in a behaviour that produces natural reward, despite substantial harm and other negative consequences. Repetitive drug use often alters brain function in ways that perpetuate craving, and weakens self-control. This phenomenon – drugs reshaping brain function – has led to an understanding of addiction as a brain disorder with a complex variety of psychosocial as well as neurobiological factors that are implicated in addiction's development. Classic signs of addiction include compulsive engagement in rewarding stimuli, preoccupation with substances or behavior, and continued use despite negative consequences. Habits and patterns associated with addiction are typically characterized by immediate gratification, coupled with delayed deleterious effects.

<span class="mw-page-title-main">Buprenorphine/naloxone</span> Opioid treatment

Buprenorphine/naloxone, sold under the brand name Suboxone among others, is a fixed-dose combination medication that includes buprenorphine and naloxone. It is used to treat opioid use disorder, and reduces the mortality of opioid use disorder by 50%. It relieves cravings to use and withdrawal symptoms. Buprenorphine/­naloxone is available for use in two different forms, under the tongue or in the cheek.

The Pennsylvania Department of Drug and Alcohol Programs is a cabinet-level agency in the Government of Pennsylvania. The objective of this department is to manage and distribute state and federal funds used to oversee alcohol and drug prevention, intervention and treatment services.

<span class="mw-page-title-main">Opioid epidemic in the United States</span> Ongoing overuse of opioid medication in the US

In the United States, the opioid epidemic is an extensive, ongoing overuse of opioid medications, both from medical prescriptions and illegal sources. The epidemic began in the United States in the late 1990s, according to the Centers for Disease Control and Prevention (CDC), when opioids were increasingly prescribed for pain management, resulting in a rise in overall opioid use throughout subsequent years. The great majority of Americans who use prescription opioids do not believe that they are misusing them.

Alongside the general opioid epidemic in the United States, there has been an increase in the number of incarcerated people in the United States experiencing opioid use disorder. Over half of the estimated 7 million incarcerated people in the United States meet the Diagnostic and Statistical Manual for Mental Disorders (DSM) criteria for substance use disorder, and only 20% receive treatment. To alleviate this problem, the United States Department of Corrections has implemented various treatment plans and programs for inmates.

<span class="mw-page-title-main">Opioid epidemic</span> Deaths due to abuse of opioid drugs

The opioid epidemic, also referred to as the opioid crisis, is the rapid increase in the overuse, misuse/abuse, and overdose deaths attributed either in part or in whole to the class of drugs called opiates/opioids since the 1990s. It includes the significant medical, social, psychological, demographic and economic consequences of the medical, non-medical, and recreational abuse of these medications.

<span class="mw-page-title-main">Prescription drug addiction</span> Medical condition

Prescription drug addiction is the chronic, repeated use of a prescription drug in ways other than prescribed for, including using someone else’s prescription. A prescription drug is a pharmaceutical drug that may not be dispensed without a legal medical prescription. Drugs in this category are supervised due to their potential for misuse and substance use disorder. The classes of medications most commonly abused are opioids, central nervous system (CNS) depressants and central nervous stimulants. In particular, prescription opioid is most commonly abused in the form of prescription analgesics.

Harm reduction consists of a series of strategies aimed at reducing the negative impacts of drug use on users. It has been described as an alternative to the U.S.'s moral model and disease model of drug use and addiction. While the moral model treats drug use as a morally wrong action and the disease model treats it as a biological or genetic disease needing medical intervention, harm reduction takes a public health approach with a basis in pragmatism. Harm reduction provides an alternative to complete abstinence as a method for preventing and mitigating the negative consequences of drug use and addiction.

In response to the surging opioid prescription rates by health care providers that contributed to the opioid epidemic in the United States, US states began passing legislation to stifle high-risk prescribing practices. These new laws fell primarily into one of the following four categories:

  1. Prescription Drug Monitoring Program (PDMP) enrollment laws: prescribers must enroll in their state's PDMP, an electronic database containing a record of all patients' controlled substance prescriptions
  2. PDMP query laws: prescribers must check the PDMP before prescribing an opioid
  3. Opioid prescribing cap laws: opioid prescriptions cannot exceed designated doses or durations
  4. Pill mill laws: pain clinics are closely regulated and monitored to minimize the prescription of opioids non-medically

References

  1. ↑ "Drug Prevention". www.scodc.org/tag/drug-prevention/.
  2. ↑ "Understanding the Epidemic | Drug Overdose | CDC Injury Center". www.cdc.gov. 2019-07-24. Retrieved 2019-10-23.
  3. ↑ Futures Of Palm Beach. (2014). Contributing Factors of Drug Abuse. Retrieved from http://www.futuresofpalmbeach.com/drug-abuse/contributing-factors/ Archived 2015-12-30 at the Wayback Machine
  4. ↑ Kilpatrick, Dean G (2000). "Risk Factors for Adolescent Substance Abuse and Dependence: Data from a National Sample". Journal of Consulting and Clinical Psychology. 68 (1): 19–30. doi:10.1037/0022-006X.68.1.19. PMID   10710837.
  5. ↑ "What are risk factors and protective factors? | National Institute on Drug Abuse (NIDA)". Drugabuse.gov. Retrieved 2013-12-10.
  6. ↑ Carver, Hannah; Elliott, Lawrie; Kennedy, Catriona; Hanley, Janet (2017-03-04). "Parent–child connectedness and communication in relation to alcohol, tobacco and drug use in adolescence: An integrative review of the literature". Drugs: Education, Prevention and Policy. 24 (2): 119–133. doi: 10.1080/09687637.2016.1221060 . hdl: 1893/25032 . ISSN   0968-7637.
  7. ↑ "Causes of Teen Drug Abuse - CDAC". cdac.info. Archived from the original on 2012-10-06.
  8. ↑ Whaley, Rachel Bridges; Hayes-Smith, Justin; Hayes-Smith, Rebecca (2010-11-28). "Gendered Pathways? Gender, Mediating Factors, and the Gap in Boys' and Girls' Substance Use". Crime & Delinquency. 59 (5): 651–669. doi:10.1177/0011128710389581. ISSN   0011-1287. S2CID   145157054.
  9. ↑ Richter, Matthias; Kunst, Anton E.; Kannas, Lasse; Willemsen, Marc; Bendtsen, Pernille; de Looze, Margreet; Nagelhout, Gera E.; Pförtner, Timo-Kolja; Lenzi, Michela (2015-06-01). "Socioeconomic inequalities in adolescent smoking across 35 countries: a multilevel analysis of the role of family, school and peers". European Journal of Public Health. 25 (3): 457–463. doi: 10.1093/eurpub/cku244 . ISSN   1101-1262. PMID   25713016.
  10. ↑ Picoito, João; Santos, Constança; Loureiro, Isabel; Aguiar, Pedro; Nunes, Carla (2019-05-10). "Gender-specific substance use patterns and associations with individual, family, peer, and school factors in 15-year-old Portuguese adolescents: a latent class regression analysis". Child and Adolescent Psychiatry and Mental Health. 13 (1): 21. doi: 10.1186/s13034-019-0281-4 . ISSN   1753-2000. PMC   6511212 . PMID   31110558.
  11. ↑ Johnston, L.D.; O’Malley, P.M.; Bachman, J.G.; and Schulenberg, J.E. Monitoring the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2013. Bethesda, MD: National Institute on Drug Abuse, 2013.
  12. ↑ "Preventing Drug Use among Children and Adolescents".
  13. ↑ Lynskey MT, Heath AC, Bucholz KK, Slutske WS, Madden PAF, Nelson EC, Statham DJ, Martin NG. Escalation of drug use in early-onset cannabis users vs co-twin controls. JAMA 289:427-33, 2003.
  14. ↑ "About Teen Rehab". Teen Rehab.
  15. ↑ Meade, Christina S.; Weiss, Roger D. (March 2007). "Substance abuse as a risk factor for HIV sexual risk behavior among persons with severe mental illness: Review of evidence and exploration of mechanisms". Clinical Psychology: Science and Practice. 14 (1): 23–33. doi:10.1111/j.1468-2850.2007.00059.x. ISSN   1468-2850.
  16. ↑ National Institute of Drug Abuse. (2003). "Preventing Drug Use among Children and Adolescents". www.drugabuse.gov/. Retrieved 6 October 2014.{{cite web}}: CS1 maint: numeric names: authors list (link)
  17. ↑ Hogue, Aaron; Liddle, Howard A. (July 1999). "Family-based preventive intervention: An approach to preventing substance use and antisocial behavior". American Journal of Orthopsychiatry. 69 (3): 278–293. doi:10.1037/h0080403. ISSN   1939-0025. PMID   10439843.
  18. ↑ Barnes, Kate. "Are Teen Drug Intervention Letters Helpful?". keytransitions.com. Retrieved 2017-10-19.
  19. ↑ Smit, Verdurmen, Monshouwer, Smil, Evelien, Jacqueline, Karin, Filip (2008). "Family interventions and their effect on adolescent alcohol use in general populations; a meta-analysis of randomized controlled trials". Drug and Alcohol Dependence. 97 (3): 195–206. doi:10.1016/j.drugalcdep.2008.03.032. PMID   18485621.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  20. ↑ Jiloha RC. Prevention, early intervention, and harm reduction of substance use in adolescents. Indian J Psychiatry. 2017 Jan-Mar;59(1):111-118. doi : 10.4103/0019-5545.204444 PMID 28529370; PMCID: PMC5418996.
  21. ↑ O'Connell, M.E., Boat, T., Warner, K.E. (2009). Preventing Mental, Emotional, and Behavioral Disorders Among Young People: Progress and Possibilities. Committee on the Prevention of Mental Disorders and Substance Abuse Among Children, Youth and Young Adults: Research Advances and Promising Interventions. Institute of Medicine; National Research Council. ISBN   9780309126748 . Retrieved 2 February 2010.{{cite book}}: CS1 maint: multiple names: authors list (link)
  22. ↑ Faggiano, Fabrizio; Minozzi, Silvia; Versino, Elisabetta; Buscemi, Daria (2014). "Universal school-based prevention for illicit drug use". The Cochrane Database of Systematic Reviews. 2014 (12): CD003020. doi:10.1002/14651858.CD003020.pub3. ISSN   1469-493X. PMC   6483627 . PMID   25435250.
  23. ↑ National Institute of Drug Abuse. "Preventing Drug Use among Children and Adolescents". www.drugabuse.gov/. Retrieved 6 October 2014.
  24. ↑ Research, Center for Drug Evaluation and (2019-09-25). "Information about Naloxone". FDA.
  25. ↑ Walley, Alexander Y.; Xuan, Ziming; Hackman, H. Holly; Quinn, Emily; Doe-Simkins, Maya; Sorensen-Alawad, Amy; Ruiz, Sarah; Ozonoff, Al (2013-01-31). "Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis". BMJ. 346: f174. doi:10.1136/bmj.f174. ISSN   1756-1833. PMC   4688551 . PMID   23372174.
  26. ↑ "Naloxone - FDA prescribing information, side effects and uses". Drugs.com. Retrieved 2019-11-21.
  27. ↑ "Narcan - FDA prescribing information, side effects and uses". Drugs.com. Retrieved 2019-11-21.
  28. ↑ lynne.walsh (2015-06-16). "Naloxone". www.samhsa.gov. Retrieved 2019-11-21.
  29. ↑ Moore, Dorothy James (2019-05-01). "Nurse Practitioners' Pivotal Role in Ending the Opioid Epidemic". The Journal for Nurse Practitioners. 15 (5): 323–327. doi: 10.1016/j.nurpra.2019.01.005 . ISSN   1555-4155. S2CID   86853490.
  30. ↑ "Nurses Can Help Minimize Opioid Crisis - NSU". Northeastern State University Online. 2018-10-18. Retrieved 2022-09-28.
  31. ↑ "Diagnosis and Treatment of Drug Abuse in Family Practice - American Family Physician Monograph". January 1, 2003.
  32. ↑ "October 2014 is National Substance Abuse Prevention Month". Office of National Drug Control Policy . 12 March 2015 – via National Archives.
  33. ↑ U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Substance Abuse Prevention (2010). "Focus On Prevention" (PDF) (HHS Publication No. (SMA) 10–4120 Revision 2010): 1. Retrieved 6 October 2014.{{cite journal}}: Cite journal requires |journal= (help)
  34. ↑ Commissioner, Office of the (2019-08-13). "Opioid Policy Steering Committee". FDA.
  35. ↑ chanell.baylor (2014-05-14). "National Helpline". www.samhsa.gov. Retrieved 2019-11-21.
  36. ↑ Abuse, National Institute on Drug. "Preventing Drug Misuse and Addiction: The Best Strategy". www.drugabuse.gov. Retrieved 2019-11-21.
  37. ↑ Abuse, National Institute on Drug (7 March 2016). "Principles of Substance Abuse Prevention for Early Childhood". www.drugabuse.gov. Retrieved 2019-11-21.
  38. ↑ Abuse, National Institute on Drug. "Preface". www.drugabuse.gov. Retrieved 2019-11-21.
  39. ↑ "Opioid Epidemic". ANA. 2017-10-19. Retrieved 2022-09-26.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.